Karuna Therapeutics, Inc. Quarterly Debt-to-equity in % from Q1 2020 to Q4 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Karuna Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q1 2020 to Q4 2023.
  • Karuna Therapeutics, Inc. Debt-to-equity for the quarter ending December 31, 2023 was 4.11 %, a 0.24% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2023 4.11 -0.01 -0.24% Dec 31, 2023
Q3 2023 3.37 -1.31 -28% Sep 30, 2023
Q2 2023 3.11 -2.02 -39.4% Jun 30, 2023
Q1 2023 3.28 -0.9 -21.5% Mar 31, 2023
Q4 2022 4.12 +0.76 +22.7% Dec 31, 2022
Q3 2022 4.68 +1.9 +68.4% Sep 30, 2022
Q2 2022 5.13 +2.9 +130% Jun 30, 2022
Q1 2022 4.18 +2.35 +128% Mar 31, 2022
Q4 2021 3.35 +1.52 +82.8% Dec 31, 2021
Q3 2021 2.78 +1.38 +98.5% Sep 30, 2021
Q2 2021 2.23 +1.04 +87.3% Jun 30, 2021
Q1 2021 1.83 +0.48 +35.5% Mar 31, 2021
Q4 2020 1.83 Dec 31, 2020
Q3 2020 1.4 Sep 30, 2020
Q2 2020 1.19 Jun 30, 2020
Q1 2020 1.35 Mar 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.